Your browser doesn't support javascript.
loading
Amyotrophic lateral sclerosis.
Kiernan, Matthew C; Vucic, Steve; Cheah, Benjamin C; Turner, Martin R; Eisen, Andrew; Hardiman, Orla; Burrell, James R; Zoing, Margaret C.
Afiliación
  • Kiernan MC; Neuroscience Research Australia and Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. m.kiernan@unsw.edu.au
Lancet ; 377(9769): 942-55, 2011 Mar 12.
Article en En | MEDLINE | ID: mdl-21296405
ABSTRACT
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system. In this Seminar, we summarise current concepts about the origin of the disease, what predisposes patients to develop the disorder, and discuss why all cases of ALS are not the same. In the 150 years since Charcot originally described ALS, painfully slow progress has been made towards answering these questions. We focus on what is known about ALS and where research is heading-from the small steps of extending longevity, improving therapies, undertaking clinical trials, and compiling population registries to the overarching goals of establishing the measures that guard against onset and finding the triggers for this neurodegenerative disorder.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Lancet Año: 2011 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Lancet Año: 2011 Tipo del documento: Article País de afiliación: Australia